While cancers such as breast, lung, and prostate frequently dominate public health discussions, there is a far less recognised but equally aggressive form - sarcoma. It affects thousands across the UK ...
GlobalData on MSN
MSD begins KANDLELIT-007 trial of calderasib for NSCLC
Newly diagnosed patients with KRAS G12C-mutant advanced or metastatic nonsquamous NSCLC will be enrolled in the trial.
VCU Massey is the first U.S. site in a global phase 2a trial for PTX-100, targeting cutaneous T-cell lymphoma. The BIPAVE-001 trial is evaluating AI-081, a PD-1 and VEGF bispecific antibody, for ...
Data recently presented at the International Association for the Study of Lung Cancer (IASLC) 2024 World Conference on Lung Cancer Treatment with Annamycin results in statistically significant ...
When most people think of cancer, names like breast, lung, or prostate cancer instantly come to mind. However, there’s another, lesser-known form called sarcoma that affects thousands of people in the ...
Soft-tissue sarcomas are tumors that can happen in many different tissues in the body. Most soft-tissue sarcomas begin in the arms, legs, or the body wall. People usually first notice a painless lump, ...
Agenus Unveils New and Updated Botensilimab Data in Colorectal, Pancreatic, Lung, Melanoma, and Sarcoma U.S. BLA Filing in Microsatellite Stable (MSS) Metastatic Colorectal Cancer (CRC) Planned for ...
Ongoing study is evaluating ability of vaccine to trigger antibodies against cancer cell ganglioside antigens. MabVax Therapeutics has received a $1.8 million Phase 2 SBIR grant from the NCI to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results